Looking for a dividend stock that offers steady income without the rollercoaster of market volatility? This specialty insurer could be the right fit. With a beta of just 0.77, the stock’s monthly returns show low correlation to the broader equity market—an ideal trait for conservative investors seeking stability in unpredictable times. Its consistent 2.55% forward yield, supported by a nearly 20-year streak of dividend increases and a low 30% payout ratio, makes it a compelling choice for retirees and safety-first income seekers. Operating in the financials sector, the company underwrites niche property and casualty insurance and provides fixed annuity products across various customer segments—allowing it to generate resilient cash flows across market cycles.
Industry-wide, insurance stocks continue to benefit from elevated interest rates, which have boosted investment income—especially for insurers with high-quality bond portfolios and exposure to alternative assets. This company has capitalized on those tailwinds, achieving reinvestment yields of 5.75% and forecasting strong long-term returns on its alternatives book. Growth has also been supported by consistently strong underwriting, with several business segments posting combined ratios under 90%. Of course, risks remain. Inflation and competitive pricing in specific insurance lines have pressured margins, and recent catastrophe events highlighted the sector’s inherent unpredictability. Still, the company’s 0.2x net leverage and strategic capital management suggest it is well-equipped to navigate such headwinds.
Following its most recent earnings call on February 4, 2025, the stock has declined 9.53%, partly reflecting a 7.84% drop in forward EPS estimates—a change that could signal either temporary headwinds or a market overreaction. With sales estimates down just 0.64%, the core business appears largely intact.
The shift in sentiment raises important questions: Is this a pullback to buy, or a red flag to heed? In our latest Safe Dividend Portfolio update, we reaffirm our position in this stock—read the full article to find out why.
